Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow ZIMMER BIOMET HOLDINGS, INC.

Get SEC filing alerts via email and in your feed for ZIMMER BIOMET HOLDINGS, INC.

ZBH

ZIMMER BIOMET HOLDINGS, INC.

About ZIMMER BIOMET HOLDINGS, INC.

Zimmer Biomet is a global medical technology company specializing in orthopedic reconstructive products, sports medicine, biologics, trauma, craniomaxillofacial, and surgical solutions. It serves healthcare providers worldwide, offering innovative devices, digital, and robotic technologies to improve patient mobility and outcomes. The company focuses on research, regulatory compliance, and strategic acquisitions to maintain competitive advantage in the musculoskeletal and surgical markets.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from ZIMMER BIOMET HOLDINGS, INC.

1
1
ZIMMER BIOMET HOLDINGS, INC. Zimmer Biomet Reports 9.3% Net Sales Increase to $2.09 Billion in Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
ZIMMER BIOMET HOLDINGS, INC. Zimmer Biomet Reports 7.2% Net Sales Increase to $8.23 Billion for Fiscal Year 2025

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
ZIMMER BIOMET HOLDINGS, INC. Zimmer Biomet Reports 9.7% Revenue Growth in Q3 2025, Net Earnings Decline

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
ZIMMER BIOMET HOLDINGS, INC. Zimmer Biomet Reports 7% Net Sales Increase in Q2 2025, Earnings Decline

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
ZIMMER BIOMET HOLDINGS, INC. Zimmer Biomet Reports 1.1% Net Sales Increase to $1.909 Billion in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
ZIMMER BIOMET HOLDINGS, INC. Zimmer Biomet Reports 3.8% Sales Increase to $7.68 Billion for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
ZIMMER BIOMET HOLDINGS, INC. Zimmer Biomet Reports 4% Net Sales Growth, Strong Earnings in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments